1. Int J Infect Dis. 2022 Dec;125:227. doi: 10.1016/j.ijid.2022.11.001. Epub 2022
 Nov 5.

Could nucleocapsid be a next-generation COVID-19 vaccine candidate - author's 
reply.

Oronsky B(1), Larson C(2), Caroen S(2), Reid TR(2).

Author information:
(1)EpicentRx Inc., Torrey Pines, CA, USA. Electronic address: 
boronsky@epicentrx.com.
(2)EpicentRx Inc., Torrey Pines, CA, USA.

Comment on
    Int J Infect Dis. 2022 Dec;125:231-232. doi: 10.1016/j.ijid.2022.11.002.

DOI: 10.1016/j.ijid.2022.11.001
PMCID: PMC9636028
PMID: 36347457 [Indexed for MEDLINE]

Conflict of interest statement: Declaration of competing interest The authors 
have no competing interests to declare.